American Journal of Managed Care News & Expert Insights | AJMC
The American Journal of Managed Care News section is a comprehensive resource for clinical news and expert insights. Read more at AJMC.
Related Articles
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain…
Breaking Barriers, Fostering Collaboration at AACR Annual Meeting 2025
Program chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD, highlight the cross-disciplinary approach to cancer research and innovation being taken…
Upadacitinib Shows Promise for Hard-to-Treat Crohn Disease
Upadacitinib showed promising results in achieving clinical and endoscopic remission in people with moderate to severe Crohn disease, including those previously treated with advanced therapies,…
Optimizing Bispecific Antibody Administration With EHR and Technology Solutions
Experts discuss the role of technology, such as electronic health record (EHR) integration, in improving the operationalization of bispecific antibodies.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal…
Evidence Supporting 2024 Guidance for Lp(a) Testing
Experts discuss the evidence supporting the National Lipid Association’s (NLA) recommendation for universal lipoprotein(a) (Lp[a]) measurement and evaluate how compelling this evidence is from a…
FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade
Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients…
Understanding How Fitness Affects Digestive Diseases
Exercise is a powerful modulator of gut health in patients with gastrointestinal (GI) conditions, as moderate activity can ease gut inflammation, reduce colorectal cancer risk,…
Assessing Patient Confidence With Biosimilars
Panelists discuss how health care professionals have varying confidence in biosimilars, driven by concerns about efficacy, safety, and interchangeability. Increased education, real-world evidence, professional engagement,…
Racial Differences in CA-125 Levels Tied to Ovarian Cancer Treatment Delays
Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at diagnosis, resulting in delayed chemotherapy…